申请人:Venenum Biodesign, LLC
公开号:US11161864B2
公开(公告)日:2021-11-02
The present invention provides compounds of Formula I′:
wherein , W, X, Y, Z, Z1, Z2, R1, R2, R3, R4 and R5 are as defined herein, or a stereoisomer, tautomer, pharmaceutically acceptable salt, prodrug ester or solvate form thereof, wherein all of the variables are as defined herein. These compounds are effective at modulating the STING protein and thus can be used as medicaments for treating or preventing disorders affected by the agonism of STING.
本发明提供了式 I′的化合物:
其中 ,W、X、Y、Z、Z1、Z2、R1、R2、R3、R4和R5如本文所定义,或其立体异构体、同分异构体、药学上可接受的盐、原药酯或溶胶形式,其中所有变量如本文所定义。这些化合物能有效调节 STING 蛋白,因此可用作治疗或预防受 STING 激动作用影响的疾病的药物。